Analyst Price Target is $33.50
▲ +956.78% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Viracta Therapeutics in the last 3 months. The average price target is $33.50, with a high forecast of $45.00 and a low forecast of $18.00. The average price target represents a 956.78% upside from the last price of $3.17.
Current Consensus is
The current consensus among 4 polled investment analysts is to buy stock in Viracta Therapeutics.